MXPA03002122A - Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. - Google Patents
Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria.Info
- Publication number
- MXPA03002122A MXPA03002122A MXPA03002122A MXPA03002122A MXPA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A
- Authority
- MX
- Mexico
- Prior art keywords
- agent
- inhibiting
- inhibition
- decrease
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
Esta invencion se relaciona con un metodo para inhibir una disminucion en el flujo transdermico de un agente que esta siendo suministrado o muestreado transdermicamente durante un periodo prolongado, en donde el suministro o muestreo involucra la ruptura de por lo menos la capa cornea de la piel para formar rutas a traves de las cuales pasa el agente; el resultado deseado se logra al cosuministrar o comuestrear el agente con una cantidad de por lo menos un agente anticicatrizacion, en donde la cantidad del agente anticicatrizacion es efectiva para inhibir una disminucion en el flujo transdermico del agente comparado con el suministro o muestreo del agente bajo condiciones substancialmente identicas, excepto en la ausencia del (los) agente(s) anticicatrizacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23116000P | 2000-09-08 | 2000-09-08 | |
PCT/US2001/027551 WO2002019985A2 (en) | 2000-09-08 | 2001-09-06 | Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03002122A true MXPA03002122A (es) | 2004-09-10 |
Family
ID=22867983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03002122A MXPA03002122A (es) | 2000-09-08 | 2001-09-06 | Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. |
Country Status (24)
Country | Link |
---|---|
US (1) | US7438926B2 (es) |
EP (1) | EP1335711B1 (es) |
JP (2) | JP5507030B2 (es) |
KR (1) | KR100764699B1 (es) |
CN (1) | CN100421653C (es) |
AT (1) | ATE367805T1 (es) |
AU (2) | AU2001288774B2 (es) |
BR (1) | BR0113749A (es) |
CA (1) | CA2422200A1 (es) |
CZ (1) | CZ2003687A3 (es) |
DE (1) | DE60129585T2 (es) |
DK (1) | DK1335711T3 (es) |
EE (1) | EE200300095A (es) |
ES (1) | ES2290166T3 (es) |
IL (1) | IL154811A0 (es) |
MA (1) | MA25958A1 (es) |
MX (1) | MXPA03002122A (es) |
NO (1) | NO20031071L (es) |
NZ (1) | NZ524646A (es) |
PL (1) | PL365603A1 (es) |
PT (1) | PT1335711E (es) |
RU (1) | RU2272618C2 (es) |
WO (1) | WO2002019985A2 (es) |
ZA (1) | ZA200302700B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0113749A (pt) * | 2000-09-08 | 2004-06-22 | Alza Corp | Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias |
BR0114909A (pt) * | 2000-10-26 | 2004-02-03 | Alza Corp | Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas |
US6908453B2 (en) * | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
WO2005004842A2 (en) * | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
AU2004253571A1 (en) * | 2003-07-02 | 2005-01-13 | Alza Corporation | Microprojection array immunization patch and method |
CA2536249A1 (en) | 2003-08-25 | 2005-03-10 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
WO2005042702A2 (en) * | 2003-10-23 | 2005-05-12 | Alza Corporation | Compositions of stabilized dna for coating microprojections |
BRPI0415466A (pt) * | 2003-10-24 | 2006-12-19 | Alza Corp | método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos |
EP1682012A4 (en) * | 2003-11-13 | 2008-09-24 | Alza Corp | COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY |
WO2005099751A2 (en) | 2004-04-01 | 2005-10-27 | Alza Corporation | Apparatus and method for transdermal delivery of influenza vaccine |
CA2562731A1 (en) * | 2004-04-13 | 2005-11-03 | Alza Corporation | Apparatus and method for transdermal delivery of fentanyl-based agents |
KR20070011481A (ko) * | 2004-04-13 | 2007-01-24 | 알자 코포레이션 | 다중 백신의 경피 전달용 기구 및 방법 |
WO2006020841A2 (en) * | 2004-08-11 | 2006-02-23 | Alza Corporation | Apparatus and method for transdermal delivery of natriuretic peptides |
KR101246015B1 (ko) | 2004-11-18 | 2013-03-20 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 마이크로니들 어레이를 접촉 코팅하는 방법 |
US8057842B2 (en) | 2004-11-18 | 2011-11-15 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
AU2005306426B2 (en) * | 2004-11-18 | 2011-04-28 | 3M Innovative Properties Company | Masking method for coating a microneedle array |
CN101160117A (zh) * | 2005-02-16 | 2008-04-09 | 阿尔扎公司 | 依泊汀-基药物的透皮释放装置和方法 |
US20070270738A1 (en) * | 2005-04-25 | 2007-11-22 | Wu Jeffrey M | Method of treating ACNE with stratum corneum piercing patch |
US20060253078A1 (en) * | 2005-04-25 | 2006-11-09 | Wu Jeffrey M | Method of treating skin disorders with stratum corneum piercing device |
WO2007002523A2 (en) | 2005-06-24 | 2007-01-04 | 3M Innovative Properties Company | Collapsible patch with microneedle array |
US20070078414A1 (en) * | 2005-08-05 | 2007-04-05 | Mcallister Devin V | Methods and devices for delivering agents across biological barriers |
WO2007061781A1 (en) * | 2005-11-18 | 2007-05-31 | 3M Innovative Properties Company | Coatable compositions, coatings derived therefrom and microarrays having such coatings |
EP2018835B1 (de) * | 2007-07-09 | 2014-03-05 | Augustinus Bader | Wirkstoff abgebendes Pflaster |
US8617487B2 (en) | 2009-03-25 | 2013-12-31 | Venture Lending & Leasing Vi, Inc. | Saliva sample collection systems |
US20120135955A1 (en) * | 2009-07-24 | 2012-05-31 | The University Of Tokyo | External Preparation Containing NSAIDs And Method For Producing The External Preparation |
EP2818159A1 (de) | 2013-06-25 | 2014-12-31 | LTS LOHMANN Therapie-Systeme AG | Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe |
US9987361B1 (en) * | 2014-12-29 | 2018-06-05 | Noven Pharmaceuticals, Inc. | Compositions and method for sustained drug delivery by active transdermal technology |
DE102017126501A1 (de) | 2017-11-10 | 2019-05-16 | Lts Lohmann Therapie-Systeme Ag | Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes |
US20190231925A1 (en) * | 2018-01-31 | 2019-08-01 | Changchun Ja Biotech. Co., Ltd. | Heparin sodium supported hydrogel sustained-release paster |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE25637E (en) | 1964-09-08 | Means for vaccinating | ||
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5458140A (en) | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
ATE177325T1 (de) * | 1994-12-09 | 1999-03-15 | Novartis Erfind Verwalt Gmbh | Transdermales system |
WO1996037256A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
WO1996037155A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical device and method for enhancing delivery of compounds through the skin |
DE19525607A1 (de) | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneales Arzneimittelfreigabesystem |
US5902603A (en) * | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
DE19541260A1 (de) * | 1995-11-06 | 1997-05-07 | Lohmann Therapie Syst Lts | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
CA2253549C (en) * | 1996-06-18 | 2005-10-25 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
CA2259437C (en) | 1996-07-03 | 2006-12-05 | Altea Technologies, Inc. | Multiple mechanical microporation of skin or mucosa |
ATE231015T1 (de) | 1996-09-17 | 2003-02-15 | Deka Products Lp | System zur medikamentenabgabe durch transport |
ES2195190T3 (es) | 1996-12-20 | 2003-12-01 | Alza Corp | Dispositivo y metodo para mejorar el flujo de agente transdermico. |
DE19654391A1 (de) | 1996-12-27 | 1998-07-02 | Basf Ag | Katalysator zur selektiven Herstellung von Propylen aus Propan |
DK1314400T3 (da) * | 1996-12-31 | 2007-10-15 | Altea Therapeutics Corp | Mikroporering af væv til levering af bioaktive midler |
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
AU739616B2 (en) * | 1997-12-11 | 2001-10-18 | Alza Corporation | Device for enhancing transdermal agent flux |
DK1037687T3 (da) * | 1997-12-11 | 2009-01-26 | Alza Corp | Anordning til at forbedre et middels transdermale strömning |
DE69831268T2 (de) * | 1997-12-11 | 2006-03-09 | Alza Corp., Palo Alto | Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses |
US6022316A (en) | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
AU767122B2 (en) | 1998-06-10 | 2003-10-30 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
EP1180053A4 (en) * | 1999-05-17 | 2006-11-08 | Kevin S Marchitto | REMOTE AND LOCAL CONTROLLED RELEASE OF PHARMACEUTICAL COMPOUNDS USING ELECTROMAGNETIC ENERGY |
DE60044084D1 (de) * | 1999-06-04 | 2010-05-12 | Georgia Tech Res Inst | Vorrichtungen zur vergrösserten penetration von mikronadeln in biologischen hautschichten |
DE60024312T2 (de) * | 1999-12-10 | 2006-08-17 | Alza Corp., Mountain View | Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür |
HU225467B1 (en) * | 1999-12-10 | 2006-12-28 | Alza Corp | Skin treatment apparatus for sustained transdermal drug delivery |
BR0113749A (pt) * | 2000-09-08 | 2004-06-22 | Alza Corp | Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias |
BR0114909A (pt) * | 2000-10-26 | 2004-02-03 | Alza Corp | Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas |
AU2003275301A1 (en) * | 2002-09-30 | 2004-04-23 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
-
2001
- 2001-09-06 BR BR0113749-2A patent/BR0113749A/pt not_active IP Right Cessation
- 2001-09-06 NZ NZ524646A patent/NZ524646A/en unknown
- 2001-09-06 EE EEP200300095A patent/EE200300095A/xx unknown
- 2001-09-06 EP EP01968531A patent/EP1335711B1/en not_active Expired - Lifetime
- 2001-09-06 DK DK01968531T patent/DK1335711T3/da active
- 2001-09-06 AU AU2001288774A patent/AU2001288774B2/en not_active Ceased
- 2001-09-06 CN CNB018185835A patent/CN100421653C/zh not_active Expired - Fee Related
- 2001-09-06 KR KR1020037003472A patent/KR100764699B1/ko not_active IP Right Cessation
- 2001-09-06 ES ES01968531T patent/ES2290166T3/es not_active Expired - Lifetime
- 2001-09-06 CZ CZ2003687A patent/CZ2003687A3/cs unknown
- 2001-09-06 RU RU2003109743/15A patent/RU2272618C2/ru not_active IP Right Cessation
- 2001-09-06 MX MXPA03002122A patent/MXPA03002122A/es active IP Right Grant
- 2001-09-06 AU AU8877401A patent/AU8877401A/xx active Pending
- 2001-09-06 AT AT01968531T patent/ATE367805T1/de not_active IP Right Cessation
- 2001-09-06 WO PCT/US2001/027551 patent/WO2002019985A2/en active IP Right Grant
- 2001-09-06 JP JP2002524470A patent/JP5507030B2/ja not_active Expired - Fee Related
- 2001-09-06 DE DE60129585T patent/DE60129585T2/de not_active Expired - Lifetime
- 2001-09-06 CA CA002422200A patent/CA2422200A1/en not_active Abandoned
- 2001-09-06 IL IL15481101A patent/IL154811A0/xx unknown
- 2001-09-06 PL PL01365603A patent/PL365603A1/xx not_active Application Discontinuation
- 2001-09-06 PT PT01968531T patent/PT1335711E/pt unknown
- 2001-09-08 US US09/950,436 patent/US7438926B2/en not_active Expired - Fee Related
-
2003
- 2003-03-07 NO NO20031071A patent/NO20031071L/no not_active Application Discontinuation
- 2003-04-07 ZA ZA200302700A patent/ZA200302700B/en unknown
- 2003-04-07 MA MA27093A patent/MA25958A1/fr unknown
-
2013
- 2013-07-09 JP JP2013143738A patent/JP2013256500A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CZ2003687A3 (cs) | 2004-01-14 |
NO20031071L (no) | 2003-05-06 |
DK1335711T3 (da) | 2007-11-26 |
MA25958A1 (fr) | 2003-12-31 |
DE60129585T2 (de) | 2008-04-17 |
US7438926B2 (en) | 2008-10-21 |
BR0113749A (pt) | 2004-06-22 |
PT1335711E (pt) | 2007-09-05 |
NZ524646A (en) | 2004-10-29 |
PL365603A1 (en) | 2005-01-10 |
JP2013256500A (ja) | 2013-12-26 |
CA2422200A1 (en) | 2002-03-14 |
JP2004508319A (ja) | 2004-03-18 |
ZA200302700B (en) | 2004-08-13 |
EP1335711B1 (en) | 2007-07-25 |
KR100764699B1 (ko) | 2007-10-08 |
CN1473037A (zh) | 2004-02-04 |
AU8877401A (en) | 2002-03-22 |
IL154811A0 (en) | 2003-10-31 |
CN100421653C (zh) | 2008-10-01 |
ATE367805T1 (de) | 2007-08-15 |
WO2002019985A3 (en) | 2002-09-06 |
US20020102292A1 (en) | 2002-08-01 |
KR20030074595A (ko) | 2003-09-19 |
EP1335711A2 (en) | 2003-08-20 |
JP5507030B2 (ja) | 2014-05-28 |
RU2272618C2 (ru) | 2006-03-27 |
AU2001288774B2 (en) | 2006-06-29 |
DE60129585D1 (de) | 2007-09-06 |
ES2290166T3 (es) | 2008-02-16 |
EE200300095A (et) | 2005-02-15 |
NO20031071D0 (no) | 2003-03-07 |
WO2002019985A2 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154811A0 (en) | Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure | |
AU2003216321A1 (en) | Tamper-resistant transdermal opioid delivery devices | |
WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
HK1068545A1 (en) | Transdermal patch for administering fentanyl | |
WO2006047392A3 (en) | Nicotinic-opioid synergy for analgesia | |
ES2017195A6 (es) | Forma de dosificacion que tiene reducidas posiblidades de abuso. | |
EP1418976A4 (en) | DEVICES AND METHODS FOR THE TITRATION OF MEDICINAL RELEASE | |
WO2003032914A3 (en) | Methods for treating substance abuse with cholinesterase inhibitors | |
AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
MXPA06001110A (es) | Uso de una combinacion de un inhibidor de la cinasa del receptor del factor de crecimiento epidermico y agentes citotoxicos para el tratamiento e inhibicion del cancer. | |
WO2002049630A3 (en) | Method for preventing or treating pain by administering an endothelin antagonist | |
MX2007005065A (es) | Forma de dosis de tiempo de retraso de farmacos para la terapia de insomnio. | |
TW200605929A (en) | Method and apparatus for reducing the incidence of tobacco use | |
MY137752A (en) | Medicament for treating aseptic inflammations containing anemonin as effective component | |
WO2001087343A3 (en) | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor | |
WO2007143185A3 (en) | Transdermal treatment of tendinopathy using glyceryl trinitrite | |
EP1108426A3 (en) | Use of prostaglandin agonists to treat erectile dysfunction or impotence | |
WO2000023062A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
EP1441718A4 (en) | CARBINOL FOR THE TREATMENT OF NEUROPATHIC FUNCTIONAL DISORDER | |
WO2007103190A3 (en) | Transdermal treatment of tendinop athy using no donor | |
GEP201606538B (en) | Preoperative treatment of post operative pain | |
WO2000025745A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
WO2001000191A3 (en) | Use of fosphenytion for the treatment of acute neuropathic pain | |
IL141117A0 (en) | Means for retaining transcutaneous catheters and needles in place |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |